Anavex Life Sciences Corp. (AVXL.OB) Alzheimer’s Drug Completes Successful Preclinical Studies
Read the full article: http://blog.qualitystocks.net/?p=12114
Anavex Life Sciences Corp (OTCBB: AVXL) will move to human clinical trials for its Alzheimer’s drug in early 2009 after preclinical studies on mice prove promising.
- Login or register to post comments
- Email this page
Related Articles
- CardioVascular Biotherapeutics Inc. (CVBT.OB) Finds Significant Private Funding for Topical Diabetic Wound Care Rollout
- Chembio Diagnostics, Inc. (CEMI.OB) Reports Strong Third Quarter Results
- Medical Connections Holdings, Inc. (MCTH.OB) Reports 58% Revenue Increase
- China Pharma Holdings Inc. (CPHI.OB) Posts Positive Q3 Results Across the Board
- Del Global Technologies Corp. (DGTC.OB) Completes Another Successful Imaging Installation